2 days ago I wrote about Janssen / Johnson & Johnson ๐, with the tentative conclusion that an ๐ช๐บ-based supply chain was solid enough to mean there would be no EU-US-J&J spat to mirror the EU-UK-AZ spat
So will J&J divert doses intended for the EU to the USA to make up for that shortfall?
The answer to that is:
* We don't know *
We have nothing yet to indicate doses are diverted
How many ๐ doses have been sent from ๐ช๐บ to ๐บ๐ธ so far?
* We don't know *
(or not with any precision anyway)
The European Commission was last week happy to announce 77 million ๐ doses exported from ๐ช๐บ to ๐ and even told us 21 million went to ๐ฌ๐ง, but what was the number to ๐บ๐ธ?
New York Times thinks it might be up to 24 million, but what of that has been sent from Netherlands already? Thanks for the link @FaktaShake, but you guessed it...
A fortnight ago I wanted to answer a question: would a ๐ช๐บ vaccine export ban be justified?
I was somehow instinctively against any such ban, and still am
But digging into it revealed the worst of out politics, media and social media, and how badly we cope with complexity
1/22
The essence of the issue is that this is both an ideological/ethical matter, and a practical one - and the interplay between the two is complicated
No person's response to the question ban-or-not can be based either all on ethics or all on practicality
2/22
Or - putting it another way - export of a small number of vaccines might be easier to justify than export of a massive number that would slow down the exporting region's own vaccination drive
OK, so next in the series of Jon looking at supply of each different COVID vaccine it's:
Novavax
This one is different to AZ, BioNTech, J&J etc., in that the EU has no APA with Novavax *yet*
Even that is somewhat confusing - Reuters reports that this is because Novavax is dragging its heels, citing production problems reuters.com/article/healthโฆ
* Very tentative conclusions on Janssen / Johnson & Johnson vaccine supply *
It looks like EU legitimately feared a UK/AstraZeneca situation with USA for J&J - that vaccine produce in NL and finished in USA would be prevented from leaving back to EU
It has been *repeatedly alleged* that J&J/Janssen vaccine being manufactured in Europe (Janssen plant in ๐ณ๐ฑ) and finished in USA *could* be a problem for EU supply of that vaccine
Iโve tried to work out if there was any other rationale for choosing that number. And I canโt find one. Iโm happy to hear if there is one, and Iโll delete this thread if so.